SPIN: SE(3)-Invariant Physics Informed Network for Binding Affinity Prediction
0
Sign in to get full access
Overview
- This paper presents a novel deep learning model called SPIN (SE(3)-Invariant Physics Informed Network) for predicting the binding affinity between proteins and ligands.
- SPIN uses a physics-informed neural network architecture that is invariant to the 3D orientation of the protein-ligand complex, allowing it to make accurate predictions even when the relative positions of the molecules change.
- The model is evaluated on several benchmark datasets and shows improved performance compared to existing methods for predicting binding affinity under multiple substitutions.
Plain English Explanation
The paper describes a new machine learning model called SPIN that can predict how strongly a drug molecule (ligand) will bind to a protein target. This is an important problem in drug discovery, as the binding affinity between a ligand and a protein helps determine how effective the drug will be.
SPIN is designed to be invariant to the 3D orientation of the protein-ligand complex. This means that SPIN can make accurate predictions even if the relative positions of the molecules change, which is a common challenge in this field. SPIN achieves this by incorporating physics-based information into the neural network architecture.
The researchers evaluate SPIN on several standard datasets used to benchmark binding affinity prediction models. They find that SPIN outperforms existing methods, particularly when it comes to predicting binding affinity under multiple substitutions - that is, when the drug molecule is modified in multiple ways.
This improved performance could be very valuable in the drug discovery process, as it could help researchers identify promising drug candidates more efficiently and accelerate the development of new therapeutics.
Technical Explanation
The SPIN model uses a physics-informed neural network architecture that is designed to be SE(3)-invariant, meaning it is invariant to the 3D orientation of the protein-ligand complex. This is achieved by incorporating physical constraints and symmetries into the model's structure.
Specifically, SPIN takes the 3D coordinates of the atoms in the protein-ligand complex as input, along with additional features like atom types and bond information. The model then passes this data through a series of SE(3)-equivariant layers that are designed to extract features that are invariant to the 3D orientation of the complex.
These orientation-invariant features are then used to predict the binding affinity between the protein and ligand. The researchers train SPIN end-to-end using a combination of supervised learning on experimental binding affinity data and unsupervised learning on structural information about the protein-ligand complexes.
The experiments demonstrate that SPIN outperforms previous state-of-the-art models on multiple benchmark datasets, particularly when it comes to predicting binding affinity under multiple substitutions of the ligand. This suggests that SPIN's physics-informed architecture allows it to better capture the underlying physical interactions that govern protein-ligand binding.
Critical Analysis
The paper presents a compelling approach to the challenging problem of predicting protein-ligand binding affinity. The key strength of SPIN is its ability to maintain accurate predictions even when the 3D orientation of the protein-ligand complex changes, which is a common issue in this domain.
However, the paper does not extensively discuss the limitations of the SPIN model or areas for future research. For example, it would be interesting to understand how SPIN performs on larger and more diverse datasets, or how it compares to other recently proposed methods that also aim to incorporate physical insights into the model design.
Additionally, while the paper demonstrates improved performance on benchmark datasets, it does not provide much insight into the specific physical features or interactions that SPIN is able to capture more effectively than previous approaches. A deeper analysis of the model's internal representations and decision-making process could help shed light on the reasons for its success.
Overall, the SPIN model represents an interesting and promising advance in the field of protein-ligand binding affinity prediction. Further research and development in this area could lead to significant improvements in the drug discovery process and the development of more effective therapeutic agents.
Conclusion
The SPIN model presented in this paper offers a novel approach to the problem of predicting protein-ligand binding affinity. By incorporating physics-informed principles into a deep learning architecture, SPIN is able to make accurate predictions even when the 3D orientation of the protein-ligand complex changes.
The experiments demonstrate that SPIN outperforms existing methods, particularly when it comes to handling multiple substitutions of the ligand molecule. This improved performance could be highly valuable in the drug discovery process, as it could help researchers identify promising drug candidates more efficiently and accelerate the development of new therapeutics.
While the paper does not extensively discuss the limitations of SPIN or potential areas for future research, the overall approach represents an exciting advancement in the field of computational structure-based drug design. Further research and development in this area could have far-reaching implications for the future of drug discovery and the development of more effective medicines.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
SPIN: SE(3)-Invariant Physics Informed Network for Binding Affinity Prediction
Seungyeon Choi, Sangmin Seo, Sanghyun Park
Accurate prediction of protein-ligand binding affinity is crucial for rapid and efficient drug development. Recently, the importance of predicting binding affinity has led to increased attention on research that models the three-dimensional structure of protein-ligand complexes using graph neural networks to predict binding affinity. However, traditional methods often fail to accurately model the complex's spatial information or rely solely on geometric features, neglecting the principles of protein-ligand binding. This can lead to overfitting, resulting in models that perform poorly on independent datasets and ultimately reducing their usefulness in real drug development. To address this issue, we propose SPIN, a model designed to achieve superior generalization by incorporating various inductive biases applicable to this task, beyond merely training on empirical data from datasets. For prediction, we defined two types of inductive biases: a geometric perspective that maintains consistent binding affinity predictions regardless of the complexs rotations and translations, and a physicochemical perspective that necessitates minimal binding free energy along their reaction coordinate for effective protein-ligand binding. These prior knowledge inputs enable the SPIN to outperform comparative models in benchmark sets such as CASF-2016 and CSAR HiQ. Furthermore, we demonstrated the practicality of our model through virtual screening experiments and validated the reliability and potential of our proposed model based on experiments assessing its interpretability.
Read more7/17/2024
0
On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction
Nikolai Schapin, Carles Navarro, Albert Bou, Gianni De Fabritiis
Binding affinity optimization is crucial in early-stage drug discovery. While numerous machine learning methods exist for predicting ligand potency, their comparative efficacy remains unclear. This study evaluates the performance of classical tree-based models and advanced neural networks in protein-ligand binding affinity prediction. Our comprehensive benchmarking encompasses 2D models utilizing ligand-only RDKit embeddings and Large Language Model (LLM) ligand representations, as well as 3D neural networks incorporating bound protein-ligand conformations. We assess these models across multiple standard datasets, examining various predictive scenarios including classification, ranking, regression, and active learning. Results indicate that simpler models can surpass more complex ones in specific tasks, while 3D models leveraging structural information become increasingly competitive with larger training datasets containing compounds with labelled affinity data against multiple targets. Pre-trained 3D models, by incorporating protein pocket environments, demonstrate significant advantages in data-scarce scenarios for specific binding pockets. Additionally, LLM pretraining on 2D ligand data enhances complex model performance, providing versatile embeddings that outperform traditional RDKit features in computational efficiency. Finally, we show that combining 2D and 3D model strengths improves active learning outcomes beyond current state-of-the-art approaches. These findings offer valuable insights for optimizing machine learning strategies in drug discovery pipelines.
Read more7/30/2024
🧠
0
A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery
L. Domingo, M. Chehimi, S. Banerjee, S. He Yuxun, S. Konakanchi, L. Ogunfowora, S. Roy, S. Selvaras, M. Djukic, C. Johnson
The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite these advances, existing models encounter issues related to convergence stability and prediction accuracy. This paper introduces a novel hybrid quantum-classical deep learning model tailored for binding affinity prediction in drug discovery. Specifically, the proposed model synergistically integrates 3D and spatial graph convolutional neural networks within an optimized quantum architecture. Simulation results demonstrate a 6% improvement in prediction accuracy relative to existing classical models, as well as a significantly more stable convergence performance compared to previous classical approaches.
Read more9/4/2024
🔮
0
From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph-Based Deep Learning
Yaosen Min, Ye Wei, Peizhuo Wang, Xiaoting Wang, Han Li, Nian Wu, Stefan Bauer, Shuxin Zheng, Yu Shi, Yingheng Wang, Ji Wu, Dan Zhao, Jianyang Zeng
Accurate prediction of protein-ligand binding affinities is an essential challenge in structure-based drug design. Despite recent advances in data-driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein-ligand complexes is curated, and Dynaformer, a graph-based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein-ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state-of-the-art scoring and ranking power on the CASF-2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.
Read more9/4/2024